Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3 (Q84748387)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 August 2011

Language	Label	Description	Also known as
English	Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3	scientific article published on 10 August 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

based on heuristic

inferred from title

Johannes Pieter Albert Baak

10

object named as

Jan P A Baak

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Emiel A M Janssen

9

object named as

Emiel A M Janssen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Einar G Gudlaugsson

4

object named as

Einar Gudlaugsson

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Feja J Voorhorst

8

object named as

Feja Voorhorst

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Ane Cecilie Munk

5

object named as

Ane Cecilie Munk

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Irene T Ovestad

1

object named as

Irene T Ovestad

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

6

object named as

Anais Malpica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Undis Vennestrøm

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Liv Andersen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Weiwei Feng

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

10 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

123

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

278-283

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Papillomavirus infections and human genital cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

How to evaluate emerging technologies in cervical cancer screening?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

The framework of pathology: good laboratory practice by quantitative and molecular methods

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Analytical characterization of the APTIMA HPV Assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Hierarchical Clustering of Human Papilloma Virus Genotype Patterns in the ASCUS-LSIL Triage Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Management of women who test positive for high-risk types of human papillomavirus: the HART study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Cervical intraepithelial neoplasia grade 3 lesions can regress

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

New approaches to cervical cancer screening in Latin America and the Caribbean

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Cervical cancer screening programs in Latin America and the Caribbean.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.07.024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84748387&oldid=2039597642"